PacBio (PACB) announced new workflows developed with Corteva Agriscience (CTVA) that enable high throughput plant and microbial genome sequencing. This collaboration, which originated at the Advances in Genome Biology and Technology, or AGBT, Agricultural meeting last year, delivers end-to-end workflows that streamline DNA extraction through library preparation, enabling Corteva to sequence thousands of samples annually, as part of their innovative seed and crop protection research and production programs. The initial phase of the collaboration saw the development of scaled DNA extraction, shearing, and library preparation workflows to characterize Corteva’s vast collection of crop and microbial samples. These novel workflows were specifically engineered to support cost-effective, ultra-high throughput long-read sequencing, opening new possibilities for studying crop genetics and diversity in a transformative way. The results of this collaboration were announced at the Advances in Genome Biology and Technology
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PACB:
- Pacific Biosciences begins commercial shipment of Revio sequencing systems
- Pacific Biosciences price target lowered to $10 from $11 at Piper Sandler
- PacBio Announces Fourth Quarter and Fiscal Year 2022 Financial Results
- Pacific Biosciences reports Q4 adjusted EPS (35c), consensus (36c)
- Pac Bio options imply 4.4% move in share price post-earnings